«X-Linked Lymphoproliferative

Below is an extended X-Linked Lymphoproliferative patents listing. Click here to return to the X-Linked Lymphoproliferative main in depth entry.

Patents :
US Patent No.	Title
7087618	Pyrazolopyridinyl pyrimidine therapeutic compounds
7163797	50 human secreted proteins
7163940	Pyrazolopyridinyl pyrimidine therapeutic compounds
7164004	Human tumor necrosis factor TR20 and methods based thereon
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7186714	Imidazo[1,2-.alpha.]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
7189690	Albumin fusion proteins
7189820	Antibodies against tumor necrosis factor delta (APRIL)
7196164	Secreted protein HHTLF25
7199120	Pyrazolo-pyridine derivatives as antiherpes agents
7211258	Protein A compositions and methods of use
7160897	Therapeutic compounds
7153863	Therapeutic compounds based on pyrazolopyridline derivatives
7153855	Pyrazolopyridinyl pyrimidine therapeutic compounds
7091315	Protein HDPBQ71
7101962	Antibodies of the P2Y10 receptor useful in altering T lymphocyte function
7109209	Pyrazolopyridines, process for their preparation and use as therapeutic compounds
7112410	Human tumor necrosis factor TR21 and methods based thereon
7118921	Incorporation and applications of biomolecular interactions within a carrier
7128906	T1 receptor-like ligand II and uses thereof
7138243	NTB-A, a surface molecule involved in natural killer cells activity
7138501	Antibodies that immunospecifically bind BLyS
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7141569	Antiviral pyrazolopyridine compounds
7217788	Human tumor necrosis factor delta polypeptides
7220840	Antibodies that immunospecifically bind to B lymphocyte stimulator protein
7378098	CXC chemokine receptor 4 agonist peptides
7378253	Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
7381800	Antibodies to HBIMF63 polypeptide
7390637	Keratinocyte derived interferon
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7411051	Antibodies to HDPPA04 polypeptide
7413903	Methods of regulating differentiation in stem cells
7419799	Compositions and methods for the treatment of immune related diseases
7425331	Protein A methods of use
7425610	Methods and materials relating to CD84-like polypeptides and polynucleotides
7375192	Antibodies that specifically bind to chemokine beta-4
7371388	Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7368531	Human secreted proteins
7226791	Polynucleotides encoding novel guanylate binding proteins (GBP's)
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7244740	Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
7247442	Antibodies to HHPEN62 polypeptide
7247626	Pyrazolopyrimidine derivatives and pharmaceutical compositions containing them
7288252	Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
7304068	Substituted pyrazolo [1,5-A] pyrimidinyls and pharmaceutical uses therefore
7312051	Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule
7368527	HADDE71 polypeptides
7429646	Antibodies to human tumor necrosis factor receptor-like 2

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.